Trial Profile
A Randomised, Single Centre, Double-blind, Two-period Cross-over Glucose Clamp Trial to Demonstrate Bioequivalence Between Insulin Detemir Produced by the NN729 Process and Insulin Detemir Produced by the Current Process in Healthy Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 16 Feb 2016
Price :
$35
*
At a glance
- Drugs Insulin detemir (Primary)
- Indications Hyperglycaemia
- Focus Pharmacokinetics
- Sponsors Novo Nordisk
- 15 Dec 2011 New trial record